メインコンテンツに移動

Tackling substance misuse "too costly for banks"

Costs of reducing operational risk caused by alcohol and drug abuse are "off-putting" to banks despite potentially huge return on investment

pill-bottles

The scale of alcohol and drug misuse in the banking industry is discouraging firms from addressing the problem because of the potential costs involved, a London conference on substance abuse heard yesterday.

John McMahon, chief executive officer at Iloumanate, a consultancy that aims to reduce the cost of alcohol misuse in the workplace, told the conference there was a strong business case for

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here